Eris Lifesciences Q2 Results
- BSE: 540596
- NSE: ERIS
- ISIN: INE406M01024
- Sector: Biotechnology & Drugs
BSE
1,467.45
91.30 (6.63%)
91.30 (6.63%)Volume22.18 K
Updated: Mon 25 Nov, 2024 | 15:43:15
NSE
1,473.7599.55 (7.24%)
99.55 (7.24%)Volume7.45 L
Updated: Mon 25 Nov, 2024 | 15:43:27
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹741.17 Cr.(2.98%)
- Operating Profit₹184.03 Cr.(5.73%)
- Profit After Tax₹91.59 Cr.(10.11%)
- Operating Margin24.83%(-9.77%)
Note: Comparison is on YoY basis
Quarterly - Eris Lifesciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 741.17 | 466.62 | -% | 505.30 | -% |
| Selling/ General/ Admin Expenses Total | 125.63 | 104.13 | -% | 98.53 | -% |
| Depreciation/ Amortization | 80.48 | 40.89 | -% | 42.09 | -% |
| Other Operating Expenses Total | 164.76 | 114.35 | -% | 131.03 | -% |
| Total Operating Expense | 557.14 | 337.77 | -% | 366.25 | -% |
| Operating Income | 184.03 | 128.85 | -% | 139.05 | -% |
| Net Income Before Taxes | 129.11 | 112.48 | -% | 126.24 | -% |
| Net Income | 91.59 | 94.85 | -% | 123.43 | -% |
| Diluted Normalized EPS | 6.72 | 6.97 | -% | 9.06 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST